U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 009296
Company: NOVARTIS
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
SERPASIL-APRESOLINE HYDRALAZINE HYDROCHLORIDE; RESERPINE 50MG;0.2MG TABLET;ORAL Discontinued None No No
SERPASIL-APRESOLINE HYDRALAZINE HYDROCHLORIDE; RESERPINE 25MG;0.1MG TABLET;ORAL Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
04/01/1954 ORIG-1 Approval Type 4 - New Combination STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
05/08/1987 SUPPL-23 Labeling

Label is not available on this site.

05/08/1987 SUPPL-22 Labeling

Label is not available on this site.

07/20/1983 SUPPL-19 Labeling

Label is not available on this site.

08/26/1985 SUPPL-18 Labeling

Label is not available on this site.

10/31/1979 SUPPL-14 Labeling

Label is not available on this site.

Back to Top